Access to CAR T-cell Clinical Trials in Underrepresented Populations: a Multicenter Cohort Study of Pediatric and Young Adult ALL Patients.

[1]  D. Teachey,et al.  Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. , 2022, Blood.

[2]  S. Steinberg,et al.  The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes , 2022, Blood advances.

[3]  R. Larson,et al.  Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia , 2022, Blood advances.

[4]  Tumaini R. Coker,et al.  Time Spent at Well Child Care Visits for English and Spanish Speaking Parents. , 2022, Academic pediatrics.

[5]  M. Zangari,et al.  Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms , 2022, JAMA network open.

[6]  M. Mushtaq,et al.  Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell (CAR T) Therapy Access. , 2022, Transplantation and cellular therapy.

[7]  S. Wheeler,et al.  Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients: a mixed methods analysis , 2022, Supportive Care in Cancer.

[8]  Snehit Prabhu,et al.  Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report , 2021, Journal of Clinical Oncology.

[9]  M. Qayed,et al.  Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia. , 2021, Current opinion in hematology.

[10]  Jonathan M Marron,et al.  Socioeconomic disparities in survival after high‐risk neuroblastoma treatment with modern therapy , 2021, Pediatric blood & cancer.

[11]  C. Thornburg,et al.  Assessment of Factors Associated With Parental Perceptions of Voluntary Decisions About Child Participation in Leukemia Clinical Trials , 2021, JAMA network open.

[12]  M. Loh,et al.  Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. , 2021, JAMA.

[13]  A. Naranjo,et al.  Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. , 2020, Journal of the National Cancer Institute.

[14]  M. Stephenson,et al.  Prevalence and Neighborhood Geomapping of COVID-19 in an Underserved Chicago Pregnant Population , 2020, American Journal of Perinatology Reports.

[15]  V. Santana,et al.  Barriers and facilitators of clinical trial enrollment in a network of community‐based pediatric oncology clinics , 2020, Pediatric blood & cancer.

[16]  R. Hubbard,et al.  Neighborhood-level measures of socioeconomic status are more correlated with individual-level measures in urban areas compared with less urban areas. , 2020, Annals of epidemiology.

[17]  R. Goldsby,et al.  Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas , 2019, Cancer medicine.

[18]  A. Seif,et al.  Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment , 2019, Leukemia & lymphoma.

[19]  Rebecca D. Kehm,et al.  Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival? , 2018, Cancer.

[20]  D. Neuberg,et al.  An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001 , 2018, Pediatric blood & cancer.

[21]  K. Davis,et al.  Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia , 2018, The New England journal of medicine.

[22]  Stephanie J. Lee,et al.  Racial and ethnic disparities in hematologic malignancies. , 2017, Blood.

[23]  Traci M. Blonquist,et al.  Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana‐Farber Cancer Institute ALL Consortium Protocols (2000–2010) , 2016, Pediatric blood & cancer.

[24]  J. Escarce,et al.  Constructing a Time-Invariant Measure of the Socio-economic Status of U.S. Census Tracts , 2016, Journal of Urban Health.

[25]  J. Sloan,et al.  Concordance between Individual vs. Area-Level Socioeconomic Measures in an Urban Setting , 2015, Journal of health care for the poor and underserved.

[26]  C. Mullighan,et al.  Acute Lymphoblastic Leukemia in Children. , 2015, The New England journal of medicine.

[27]  S. Gahagan,et al.  Participation in pediatric oncology research protocols: Racial/ethnic, language and age‐based disparities , 2015, Pediatric blood & cancer.

[28]  H. Adami,et al.  Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  L. Sharp,et al.  Traveling Towards Disease: Transportation Barriers to Health Care Access , 2013, Journal of Community Health.

[30]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[31]  Shari Bolen,et al.  Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review , 2008, Cancer.

[32]  Shari Bolen,et al.  Provider roles in the recruitment of underrepresented populations to cancer clinical trials , 2007, Cancer.

[33]  G. Hortobagyi,et al.  Factors associated with participation in breast cancer treatment clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  N. Heerema,et al.  Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. , 2002, Blood.

[35]  L. Chambless,et al.  Neighborhood of residence and incidence of coronary heart disease. , 2001, The New England journal of medicine.

[36]  D. Gandara,et al.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  J. Shuster,et al.  Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. Fluchel,et al.  Financial Burden of Pediatric Cancer for Patients and Their Families. , 2015, Journal of oncology practice.

[39]  rechecks 2°responsibility,et al.  Medical Oncology , 2020, Definitions.